Cullinan Associates Inc Johnson & Johnson Transaction History

Cullinan Associates Inc

  • $1.81 Billion
  • Q3 2024

A detailed history of Cullinan Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Cullinan Associates Inc holds 222,005 shares of JNJ stock, worth $32.1 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
222,005
Previous 229,326 3.19%
Holding current value
$32.1 Million
Previous $33.5 Million 7.34%
% of portfolio
1.99%
Previous 1.92%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$145.48 - $167.38 $1.07 Million - $1.23 Million
-7,321 Reduced 3.19%
222,005 $36 Million
Q2 2024

Jul 10, 2024
SELL
$144.38 - $157.78 $1.37 Million - $1.49 Million
-9,465 Reduced 3.96%
229,326 $33.5 Million
Q1 2024

Apr 18, 2024
BUY
$155.22 - $162.74 $5.1 Million - $5.35 Million
32,875 Added 15.97%
238,791 $37.8 Million
Q4 2023

Jan 24, 2024
SELL
$145.6 - $158.88 $2.5 Million - $2.73 Million
-17,167 Reduced 7.7%
205,916 $32.3 Million
Q3 2023

Oct 11, 2023
BUY
$155.75 - $174.48 $2.43 Million - $2.73 Million
15,631 Added 7.53%
223,083 $34.7 Million
Q2 2023

Jul 14, 2023
BUY
$154.35 - $166.11 $1.08 Million - $1.16 Million
7,001 Added 3.49%
207,452 $34.3 Million
Q1 2023

Apr 05, 2023
BUY
$151.05 - $180.26 $316,902 - $378,185
2,098 Added 1.06%
200,451 $31.1 Million
Q4 2022

Jan 11, 2023
BUY
$160.2 - $179.79 $804,684 - $903,085
5,023 Added 2.6%
198,353 $35 Million
Q3 2022

Oct 19, 2022
SELL
$161.33 - $179.52 $264,581 - $294,412
-1,640 Reduced 0.84%
193,330 $31.6 Million
Q2 2022

Jul 08, 2022
BUY
$168.19 - $186.01 $1.43 Million - $1.58 Million
8,479 Added 4.55%
194,970 $34.6 Million
Q1 2022

Apr 21, 2022
BUY
$158.14 - $179.59 $889,537 - $1.01 Million
5,625 Added 3.11%
186,491 $33.1 Million
Q4 2021

Jan 07, 2022
BUY
$155.93 - $173.01 $660,519 - $732,870
4,236 Added 2.4%
180,866 $30.9 Million
Q3 2021

Oct 08, 2021
BUY
$161.5 - $179.47 $849,813 - $944,371
5,262 Added 3.07%
176,630 $28.5 Million
Q2 2021

Jul 07, 2021
BUY
$159.48 - $171.07 $3.55 Million - $3.81 Million
22,260 Added 14.93%
171,368 $28.2 Million
Q1 2021

Apr 20, 2021
BUY
$153.07 - $170.48 $572,787 - $637,936
3,742 Added 2.57%
149,108 $24.5 Million
Q4 2020

Jan 14, 2021
BUY
$137.11 - $157.38 $421,613 - $483,943
3,075 Added 2.16%
145,366 $22.9 Million
Q3 2020

Oct 09, 2020
BUY
$140.38 - $153.83 $310,380 - $340,118
2,211 Added 1.58%
142,291 $21.2 Million
Q2 2020

Jul 07, 2020
SELL
$128.81 - $155.51 $84,756 - $102,325
-658 Reduced 0.47%
140,080 $19.7 Million
Q1 2020

Apr 01, 2020
SELL
$111.14 - $153.99 $55,236 - $76,533
-497 Reduced 0.35%
140,738 $18.5 Million
Q4 2019

Jan 15, 2020
BUY
$127.5 - $146.44 $225,675 - $259,198
1,770 Added 1.27%
141,235 $20.6 Million
Q3 2019

Oct 01, 2019
BUY
$126.95 - $142.14 $7,617 - $8,528
60 Added 0.04%
139,465 $18 Million
Q2 2019

Jul 16, 2019
BUY
$131.15 - $144.24 $1.4 Million - $1.54 Million
10,677 Added 8.29%
139,405 $19.4 Million
Q1 2019

Apr 30, 2019
BUY
$125.72 - $139.79 $84,735 - $94,218
674 Added 0.53%
128,728 $18 Million
Q4 2018

Jan 11, 2019
BUY
$122.84 - $147.84 $4,299 - $5,174
35 Added 0.03%
128,054 $16.5 Million
Q3 2018

Oct 19, 2018
SELL
$121.58 - $142.88 $602,064 - $707,541
-4,952 Reduced 3.72%
128,019 $17.7 Million
Q2 2018

Jul 09, 2018
SELL
$119.4 - $131.76 $148,891 - $164,304
-1,247 Reduced 0.93%
132,971 $16.1 Million
Q1 2018

Apr 27, 2018
BUY
$125.1 - $148.14 $332,766 - $394,052
2,660 Added 2.02%
134,218 $17.2 Million
Q4 2017

Jan 17, 2018
SELL
$131.22 - $143.62 $411,374 - $450,248
-3,135 Reduced 2.33%
131,558 $18.4 Million
Q3 2017

Oct 16, 2017
BUY
$129.47 - $135.38 $17.4 Million - $18.2 Million
134,693
134,693 $17.5 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email